PHARMARON (03759) announced that on January 28, 2026, the company issued 81,600 A shares to employees of the group under the 2021 A-Share Restricted Stock Incentive Plan, which was approved by a special resolution passed at the extraordinary general meeting, A-share class meeting, and H-share class meeting held on July 12, 2021.
Separately, the company issued 565,700 A shares to employees of the group on January 28, 2026, under the 2022 A-Share Restricted Stock Incentive Plan, which was approved by a special resolution passed at the extraordinary general meeting, A-share class meeting, and H-share class meeting held on May 31, 2022.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments